Atezolizumab | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Atezolizumab
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Atezolizumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 USDMF, 3 Listed Suppliers

4 API Suppliers
1 USDMF
3 Listed Suppliers

DEVELOPMENTS

860 Drugs in Development

860 Drugs in Development

FINISHED DOSAGE FORMULATIONS

75 FDF Dossiers, 3 FDA Orange Book, 19 Europe, 3 Canada, 48 Australia, 2 South Africa

75 FDF Dossiers
3 FDA Orange Book
19 Europe
3 Canada
48 Australia
2 South Africa

DIGITAL CONTENT

336 News #PharmaBuzz

336 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Regulatory FDF Prices, 8 Annual Reports

1 US Medicaid Prescriptions
5 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 Health Canada Patents

9 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

9 All

01 9Gowling WLG

filter Patent Reset all filters

9 All

01 32740806

02 32905798

03 32925310

filter Product Reset all filters

9 All

01 9ATEZOLIZUMAB

filter Dosage Reset all filters

9 All

01 9SOLUTION

filter Exp Date Reset all filters

9 All

01 32029-12-08

02 32034-03-12

03 32034-09-26

Product Main Page

01

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2740806

Filing Date : 2009-12-08

Strength per Unit : 1200mg / 20ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2925310

Filing Date : 2014-09-26

Strength per Unit : 1200mg / 20ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2905798

Filing Date : 2014-03-12

Strength per Unit : 1200mg / 20ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2740806

Filing Date : 2009-12-08

Strength per Unit : 840mg / 14ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2925310

Filing Date : 2014-09-26

Strength per Unit : 840mg / 14ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2905798

Filing Date : 2014-03-12

Strength per Unit : 840mg / 14ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

ATEZOLIZUMAB

Brand Name : TECENTRIQ SC

Patent Number : 2905798

Filing Date : 2014-03-12

Strength per Unit : 125 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

ATEZOLIZUMAB

Brand Name : TECENTRIQ SC

Patent Number : 2925310

Filing Date : 2014-09-26

Strength per Unit : 125 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Gowling WLG

ATEZOLIZUMAB

Organic Process R&D

Not Confirmed

Gowling WLG

Country

Organic Process R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

ATEZOLIZUMAB

Brand Name : TECENTRIQ SC

Patent Number : 2740806

Filing Date : 2009-12-08

Strength per Unit : 125 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!